Corporate News 04-Jul-18
Unichem Laboratories received final ANDA approval for Montelukast Chewable Tablets
From USFDA
Unichem Laboratories has received final ANDA approval for its Montelukast Chewable Tablets, 4 mg and 5 mg from the USFDA to market a generic version of Merck Sharp & Dohme Corporation's Singulair Tablets, 4 mg and 5 mg.
Previous News
Unichem Lab gets USFDA nod for chronic angina drug
( Hot Pursuit - 17-Mar-23 13:21 )
Board of Unichem Laboratories recommends final dividend
( Corporate News - 28-May-22 16:35 )
Unichem Lab receives ANDA approval for Divalproex Sodium ER tablets
( Corporate News - 28-Feb-22 12:33 )
Unichem Laboratories to table results
( Corporate News - 20-May-22 16:02 )
Unichem Laboratories receives USFDA approval for Zonisamide Capsules
( Corporate News - 27-Jan-21 14:50 )
Board of Ipca Laboratories approves acquisition of 33.38% stake in Unichem Laboratories
( Corporate News - 24-Apr-23 16:06 )
Unichem settles patent dispute for generic tadalafil (Cialis®)
( Corporate News - 20-Jun-18 14:16 )
Unichem Laboratories to convene board meeting
( Corporate News - 04-Nov-22 14:16 )
Unichem Laboratories to hold board meeting
( Corporate News - 12-Jul-18 17:30 )
Unichem Laboratories fixes record date for interim dividend
( Market Beat - Reports 09-Mar-16 14:52 )
Unichem Labs gets US FDA nod for bipolar treatment drug
( Hot Pursuit - 28-Feb-22 11:58 )
Other Stories
Tridhya Tech to convene board meeting
03-Jul-24 20:06
Sonu Infratech schedules EGM
03-Jul-24 19:59
Sakuma Exports to convene AGM
03-Jul-24 19:59
Time Technoplast repays commercial paper
03-Jul-24 18:31
Board of Aditya Vision approves stock split and listing of share on NSE
03-Jul-24 18:24
Pricol director resigns
03-Jul-24 18:21
Board of VMS Industries recommends first interim dividend
03-Jul-24 17:49
Lakshmi Machine Works to declare Quarterly Result
03-Jul-24 17:44
Modison to convene AGM
03-Jul-24 17:43
Sybly Industries to discuss results
03-Jul-24 17:43
Back
Top
